Precigen, Inc. Net Debt/EBITDA

Net Debt/EBITDA of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.


Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending June 30, 2022 was -4.56 (a -35.91% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA increased by 27.45%
  • Annual Net Debt/EBITDA for 2021 was -1.22 (a 4.53% increase from previous year)
  • Annual Net Debt/EBITDA for 2020 was -1.16 (a -11.56% decrease from previous year)
  • Annual Net Debt/EBITDA for 2019 was -1.32 (a -4370.13% decrease from previous year)
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of Precigen, Inc.

Most recent Net Debt/EBITDAof PGEN including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of Precigen, Inc.

Precigen, Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -4.56 -7.11
2021 -4.6 -3.58 -6.54 -6.06 -1.22
2020 -2.51 -4.96 18.41 -7.6 -1.16
2019 2.83 -3.79 -3.01 -0.79 -1.32
2018 0.06 1.43 3.54 2.76 0.03
2017 -2.41 2.77 4.29 9.22 0.9
2016 19.75 10.23 -40.1 20.59 5.81
2015 7.41 -7.54 -22.22 0.86 1.18
2014 1.97 -4.4 -9.62 5.88 2.21
2013 8.68 5.22 6.34 0.0 2.9
2012 0.0 0.0 0.17
2011 0.0 0.26

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology